Back to search

United Kingdom· GB-APID-4691711000001106

Daunorubicin 20mg powder for solution for infusion vials

A daunorubicin product containing daunorubicin, registered in United Kingdom by Zentiva Pharma UK Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC L01DB02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedDaunorubicin 20mg powder for solution…ATCL01DB02REGISTER NO.GB-APID-4691711000001…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Daunorubicin is registered in 13 of 19 countries.

Countries holding a registration under ATC L01DB02 (daunorubicin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 6 of them publish a price we can compare per daily dose

Daunorubicin · ATC L01DB02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Daunorubicin
Manufacturer
Zentiva Pharma UK Ltd
Country
United Kingdom (GB)
ATC code
L01DB02
ATC class
Daunorubicin
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5013011003033
  • gtin
    8594739236271

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

440 interactions on record for daunorubicin.

Graded by severity as the source publishes them — 98 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Daunorubicin · interactions on record

440 records

  • 98 severe
  • 332 moderate
  • 10 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Daunorubicin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All daunorubicin products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Daunoblastin
  • Belgium · Cerubidine, Daunorubicine Hikma
  • Germany · Daunoblastin
  • Denmark · Daunorubicin ”hikma"
  • Estonia · Daunoblastina
  • Spain · Daunoblastina
  • Finland · Daunorubicin Hikma
  • France · Cerubidine, Daunorubicin Hikma
  • Croatia · Daunoblastina
  • Hungary · Daunoblastina
  • Ireland · Cerubidin
  • Italy · Daunoblastina
  • Luxembourg · Cerubidine
  • Netherlands · Cerubidine, Daunorubicine Hikma
  • Norway · Cerubidin, Daunorubicin Hikma
  • Portugal · Daunorrubicina Hikma
  • Sweden · Cerubidin, Daunorubicin Hikma
  • Slovakia · Daunoblastina

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b3e0abb9-e6b1-4ccd-8ccc-d663ee503999
GET /v1/drugs/b3e0abb9-e6b1-4ccd-8ccc-d663ee503999?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4691711000001106",
  "desc": "Daunorubicin 20mg powder for solution for infusion vials (Zentiva Pharma UK Ltd)",
  "form": "Powder for solution for infusion",
  "vpid": "41785411000001102",
  "source": "dmd",
  "vtm_id": "773356007",
  "strength": "20 mg",
  "substance": "Daunorubicin",
  "ingredient": "Daunorubicin hydrochloride",
  "supplier_code": "9043311000001106"
}

See everything about daunorubicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.